Intravenous Infusions is trading 8.3% up today at GHS 0.39 as a strategic stake acquisition by CCM Healthcare Investments continues to fuel a multi-day rally.
- Dubai-based CCM Healthcare Investments acquired over 1 million shares, attracting significant investor interest and keeping momentum elevated since early July.
- The stock's performance is further bolstered by broader strength across the healthcare sector.